4.7 Article

New Generation of Inactivated Poliovirus Vaccines for Universal Immunization after Eradication of Poliomyelitis

期刊

CLINICAL INFECTIOUS DISEASES
卷 47, 期 12, 页码 1587-1592

出版社

OXFORD UNIV PRESS INC
DOI: 10.1086/593310

关键词

-

资金

  1. National Institute of Allergy and Infectious Diseases, National Institutes of Health
  2. US Food and Drug Administration
  3. US Department of Health and Human Services

向作者/读者索取更多资源

Twenty years of global polio eradication efforts may soon eliminate the transmission of wild-type poliovirus. However, new information that has been learned about poliovirus, as well as the political realities of a modern world, demand that universal immunity against poliomyelitis be maintained, even after wild-type poliovirus is eradicated. Although 2 excellent vaccines have proven to be highly effective in the past, neither the live-attenuated vaccine nor the currently used inactivated vaccine are optimal for use in the posteradication era. Therefore, concerted efforts are urgently needed to develop a new generation of vaccine that is risk-free and affordable and can be produced on a global scale. Here, we discuss the desired properties of a vaccine and methods to create a new polio vaccine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据